Author: Garreth

GP contract agreement England 2020/21

The final version of the GP Contract which sets out requirements and funding for the new Primary Care Networks was published in February. Some significant changes were made in response to consultation, including one relevant to the delivery of “additional roles” which, amongst other things, will help fund the roll out of First Contact Practitioners. The two main changes are an expansion of the roles and an increase in the funding from 70% to 100% of salary. Many of the new roles are also important for MSK health.…

Read more of this article

New how-to guide: non face-to-face clinics

The NHS Long Term Plan includes commitments to remove the need for up to a third of outpatient appointments over the next five years, saving patients 30 million trips to hospital and the NHS more than £1 billion a year in new expenditure, and to continue to provide patients with a wide choice of options for quick elective care. ARMA hosted a webinar recently on this in relation to rheumatology services.

This new website from UCL Partners includes a range of resources aimed at supporting colleagues / partners in the planning and implementation of non face-to-face models of care.…

Read more of this article

FSEM-NCSEM joint conference announced

Registration is now open for the second joint conference organised by the Faculty of Sport and Exercise Medicine (FSEM) and the National Centre for Sport and Exercise Medicine (NCSEM). This year’s theme is ‘From Science to Services’, and the various speakers and workshops will aim to explore how cutting-edge sport, exercise and physical activity research is driving improvements in healthcare.

The conference will be held at the Advanced Wellbeing Research Centre in Sheffield on Thursday, 30 April 2020.

To find out more, or to book your place, visit the FSEM website.

Paediatric rheumatology webinar

Upcoming webinar: Paediatric rheumatology: lived experience and psychological needs

Friday 27 March 12.30 – 1.30

Around 12,000 children and young people in the UK have a musculoskeletal condition. Supporting them to live the lives they want is an important part of treating their conditions. This webinar will discuss these issues using the example of Juvenile Dermatomyositis (JDM), a rare condition affecting just 3 in a million children in the UK.

Polly Livermore is a rheumatology nurse who has studied the psychological needs of children with JDM.…

Read more of this article

ARMA roundtable on Pain

ARMA roundtable on Pain

In October 2019 ARMA held a roundtable bringing together people working on chronic pain from a range of perspectives to discuss what might be done to improve the experience of people living with chronic pain. Around 10–14% of people (6 – 8 million) experience moderate to severely disabling pain. Currently services and support for these people are difficult to access. Whilst not all chronic pain is musculoskeletal, osteoarthritis and back pain are associated with over half of all chronic pain, so that the lack of support is a key issue for us. …

Read more of this article

iO research and reports

The Institute of Osteopathy has recently published additional reports, including the impact of Multidisciplinary management of low back pain and sciatica in primary care. This impact report provides an overview of the Plymouth Community Back Pain Service which has delivered a sustainable primary care service with measurable outcomes run by a multidisciplinary team including GPs, osteopaths, cognitive behavioural therapists and physiotherapists.

To see all recent publications, visit the iO Research and Reports page.

NHS extends testing of non-urgent care waiting times target changes

If you are referred for specialist non-urgent treatment, you currently should expect to be treated within a maximum waiting time of 18 weeks. Over the last year, the NHS has been reviewing this 18-week target. ARMA has been involved in the advisory group looking at this change.

The NHS England board meeting on 30 January announced plans to extend the testing period for proposed changes to the 18-week elective care measure into 2020/21.

This joint response was issued by National Voices, The Arthritis and Musculoskeletal Alliance, Versus Arthritis, the MS Society, the Neurological Alliance and Healthwatch England.…

Read more of this article

NICE Quality Standard – Rheumatoid arthritis in over 16s

In January 2020, NICE published an update on the Quality Standard for rheumatoid arthritis in over 16s (QS33). This quality standard covers assessing, diagnosing and managing rheumatoid arthritis in over 16s. It describes high-quality care in priority areas for improvement.

NICE thanked organisations that submitted comments during the consultation period. All consultation comments were considered by the advisory committee (QSAC) and are documented in the minutes of this meeting.

Also available on the website is a summary of the consultation comments prepared by the NICE quality standards team and the full set of consultation comments.…

Read more of this article

Feedback on NICE behaviour change guideline

NICE is developing a guideline on Behaviour change: digital and mobile health interventions and ARMA has been invited to register as a stakeholder.

Behaviour change interventions have been considered in relation to the following areas:

  • eating patterns
  • physical activity
  • smoking
  • harmful drinking
  • sexual health
  • mental wellbeing

The consultation for this guideline opened on Friday 24 January. It will close at 5pm on Friday 6 March. If your organisation would like to have the opportunity to comment, you will first need to register as a stakeholder.…

Read more of this article